Guardant Health: Asymptomatic Screening Creating An Asymmetric Opportunity
Guardant Health is overcoming skepticism with new cancer tests. Learn why GH stock is a buy, with strong growth and a shift ...
technologynetworks9d
Organoids, Beyond the Hype
The HUMANOID Center at UC San Diego is pioneering organoid research aimed at improving the reliability and reproducibility of ...
Nature10d
Overcoming barriers in biomarker-driven global clinical trials with solid tumour profiling
This webcast will highlight how one such tool, the Labcorp Tissue Complete CGP service, offered by Labcorp’s global laboratories, provides a sample ... and 2 genomic signatures in 505 cancer ...
MM&M1d
Pharma brands are struggling to keep the attention of digitally savvy HCPs
It’s critical to understand what a digitally savvy HCP is in 2025 and what’s impeding pharma's communications with this ...
Pharmaceutical Technology19d
The AI advantage in discovering new medicines
With continued investment and growing buzz from the industry, the AI hype is expected to extend through 2025 and beyond.
pharmaphorum5d
Trends in pharmaceutical R&D outsourcing
R&amp,D outsourcing involves pharmaceutical companies subcontracting parts of their R&amp,D efforts to third-party service providers. Small or mid-sized pharmaceutical or biotech houses may use ...
Wall Street Journal5d
Pharma Companies Turn to AI to Speed Up Drug Development, But Hit Hurdles
When Genentech licensed experimental drug vixarelimab from Kiniksa Pharmaceuticals KNSA-1.57%decrease; red down pointing triangle, its scientists thought they had a future lung medicine in their ...
pharmaphorum3d
Transforming pharma R&D with a scientist-centric approach to AI & automation
Markus Gershater looks at how automation and artificial intelligence (AI) can transform pharma R&D. Due to increasing complexity in R&D, pharma teams are under pressure to drive down costs and ...
Pharmabiz18d
Indian pharma faces decline in R&D productivity, patent expiries, turns to AI to mitigate challenges
Indian pharmaceutical companies are grappling with significant challenges, including declining R&D productivity, patent expirations, and increased scrutiny from global regulators. To address these ...
WSIL-TV13d
Human brain samples contain an entire spoon’s worth of nanoplastics, study says
(CNN) — Cognitively normal human brain samples collected at autopsy in ... Regents’ Professor and professor of pharmaceutical sciences at the University of New Mexico in Albuquerque.
Bloomberg L.P.22d
Ascentage Pharma’s US Shares Climb After $126 Million IPO
Shares of Ascentage Pharma Group International pared earlier losses to rise 0.75% in the Chinese biopharmaceutical company’s US trading debut, after pricing its $126.4 million initial public ...
Yakima Herald-Republic13d
Commentary: Big Pharma should disclose prices on drug advertisements
The uniquely American phenomenon of pharmaceutical advertising. If you turn on the nightly news, scroll Instagram or stream your favorite show, you are likely to be bombarded by commercials for ...